Cases & Deals

CTI Life Sciences Fund, Panacea Venture, and 3B Future Health Fund co-lead $42 million Series A funding of Domain Therapeutics

Clients CTI Life Sciences Fund, Panacea Venture, and 3B Future Health Fund

Jones Day represented CTI Life Sciences Fund, Panacea Venture, and 3B Future Health Fund as co-leaders in the $42 million Series A financing round of Domain Therapeutics, a biopharmaceutical company specializing in the research and development of innovative drugs targeting G Protein-Coupled Receptors (GPCRs) in immuno-oncology, along with other investors.